Femara 2.5Mg Tablet Contains Letrozole 2.5Mg, A Selective Aromatase Inhibitor. It Is Primarily Used In The Treatment Of Hormone Receptor-Positive Breast Cancer In Postmenopausal Women And Is Also Indicated For Infertility Treatment By Inducing Ovulation In Women With Anovulation Or Irregular Menstrual Cycles. Letrozole Works By Inhibiting The Enzyme Aromatase, Which Reduces Estrogen Production In The Body, Thereby Slowing The Growth Of Estrogen-Dependent Cancer Cells And Stimulating Ovulation. Side Effects Common Side Effects May Include: Hot Flashes Nausea Or Vomiting Fatigue Joint Or Muscle Pain Serious Side Effects Are Rare But May Include: Osteoporosis Or Bone Density Reduction Severe Allergic Reactions (Rash, Swelling, Or Itching) Increased Risk Of Cardiovascular Issues If You Experience Severe Or Persistent Symptoms, Contact A Healthcare Provider Immediately. Precautions Before Using Femara 2.5Mg Tablet, Observe The Following Precautions: Pregnancy: Femara Is Contraindicated During Pregnancy Due To The Risk Of Fetal Harm. Breastfeeding: Do Not Use During Breastfeeding, As It Can Affect The Baby. Bone Density Monitoring: Long-Term Use May Lead To Bone Loss; Monitor Bone Health Regularly. Liver Function: Use Cautiously In Patients With Compromised Liver Function. Allergy: Avoid Use In Individuals With A Known Allergy To Letrozole Or Any Of Its Components.